Suchergebnisse - "Burhenne, Jürgen"

PubPharm (88)

1

Time Course of the Interaction Between Oral Short-Term Ritonavir Therapy with Three Factor Xa Inhibitors and the Activity of CYP2D6, CYP2C19, and CYP3A4 in Healthy Volunteers

enthalten in: Clinical pharmacokinetics | 2024

von Rohr, B. | Krohmer, E. | Foerster, K. | +5

2

Effect of Tacrolimus Formulation (Prolonged-Release vs Immediate-Release) on Its Susceptibility to Drug-Drug Interactions with St. John's Wort

enthalten in: Clinical pharmacology in drug development | 2024

von Gümüs, K. | Teegelbekkers, A. | Sauter, M. | +6

3

Protocol of the IntenSify-Trial : An open-label phase I trial of the CYP3A inhibitor cobicistat and the cytostatics gemcitabine and nab-paclitaxel in patients with advanced stage or metastatic pancreatic ductal adenocarcinoma to evaluate the combination's pharmacokinetics, safety, and efficacy

enthalten in: Clinical and translational science | 2023

von Hohmann, N. | Sprick, M. | Pohl, M. | +19

4

CYP3A and CYP2C19 Activity Determined by Microdosed Probe Drugs Accurately Predict Voriconazole Clearance in Healthy Adults

enthalten in: Clinical pharmacokinetics | 2023

von Muhareb, A. | Blank, A. | Meid, A. | +5

5

Persister cell phenotypes contribute to poor patient outcomes after neoadjuvant chemotherapy in PDAC

enthalten in: Nature cancer | 2023

von Zhou, X. | An, J. | Kurilov, R. | +23

6

The first-in-class ERK inhibitor ulixertinib shows promising activity in mitogen-activated protein kinase (MAPK)-driven pediatric low-grade glioma models

enthalten in: Neuro-oncology | 2023

von Sigaud, R. | Rösch, L. | Gatzweiler, C. | +26

7

Frailty as a Marker for the Plasma Concentrations of Direct Oral Anticoagulants in Older Patients : Results of an Exploratory Study

enthalten in: Drugs & aging | 2023

von Eidam, A. | Marji, J. | Benzinger, P. | +8

8

Quantification of the Time Course of CYP3A Inhibition, Activation, and Induction Using a Population Pharmacokinetic Model of Microdosed Midazolam Continuous Infusion

enthalten in: Clinical pharmacokinetics | 2022

von Nassar, Y. | Hohmann, N. | Michelet, R. | +7

9

Risk of Cerebrovascular Events in Intracerebral Hemorrhage Survivors With Atrial Fibrillation : A Nationwide Cohort Study

enthalten in: Stroke | 2022

von Nielsen, P. | Melgaard, L. | Overvad, T. | +52

10

MYCN mediates cysteine addiction and sensitizes neuroblastoma to ferroptosis

enthalten in: Nature cancer | 2022

von Alborzinia, H. | Flórez, A. | Kreth, S. | +36

CommentIn: Clin Transl Med. 2022 Aug;12(8):e963. - PMID 35908258

1
2
3
4
5
6
7
8
9
Nächster »
[9]